Skip to Main Content

Advertisement

Skip Nav Destination

Editor's Corner


Go for the Goal

December 2022

Aaron Gerds, MD

Dr. Aaron Gerds discusses the value in taking shots and "going for the goal" in hematology, including advocating for issues like access to maternal healthcare and insurance reforms.

KHE: A Locally Invasive Vascular Anomaly of Early Childhood

December 2022

KHE is a rare and locally aggressive vascular tumor, as classified by the International Society for the Study of Vascular Anomalies. It usually presents as a cutaneous vascular lesion that infiltrates the subcutaneous and deeper tissues.

Pulling Back the Curtain: Robert A. Brodsky, MD

December 2022

In this edition, Robert A. Brodsky, MD, discusses advances in sickle cell treatment, his passion for being a physician-scientist, and the beauty of hematology.

Real-World Data Support Licensed Use of Tisagenlecleucel in Infants, Young Children With B-Cell ALL

December 2022

Researchers used real-world data to assess the feasibility and activity of tisagenlecleucel in infants and children younger than 3. The international, multicenter, retrospective study used data from 38 patients screened at 15 hospitals across 10 countries.

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement